Bank Of America Corp Exagen Inc. Transaction History
Bank Of America Corp
- $1.19 Trillion
- Q3 2024
A detailed history of Bank Of America Corp transactions in Exagen Inc. stock. As of the latest transaction made, Bank Of America Corp holds 6,233 shares of XGN stock, worth $19,758. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,233
Previous 6,092
2.31%
Holding current value
$19,758
Previous $11,000
72.73%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding XGN
# of Institutions
38Shares Held
6.41MCall Options Held
4.5KPut Options Held
400-
Rtw Investments, LP New York, NY1.51MShares$4.79 Million0.07% of portfolio
-
Cowen And Company, LLC891KShares$2.83 Million0.07% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY541KShares$1.71 Million0.01% of portfolio
-
Stonepine Capital Management, LLC Bend, OR534KShares$1.69 Million1.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$1.56 Million0.0% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $51.5M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...